Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.23 | 0.0006 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.46 | 0.005 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.005 |